Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada.
Faculty of Applied Health Sciences, University of Waterloo, Waterloo, ON, Canada.
Acupunct Med. 2023 Apr;41(2):63-72. doi: 10.1177/09645284221076504. Epub 2022 May 24.
To assess the effectiveness of acupuncture for the treatment of Raynaud's syndrome by conducting a systematic review and meta-analysis of randomized controlled trials (RCTs).
Studies were identified from English and Chinese databases from their inception to September 2020. The outcomes of interest were remission incidence, number of daily attacks, incidence of positive cold stimulation tests and incidence of cold provocation tests. We conducted meta-analysis and network meta-analysis using meta and gemtc.
Six trials (n = 272 participants) were included in the meta-analysis. Pairwise meta-analyses show that acupuncture was associated with increased remission incidence (risk ratio (RR) = 1.21, 95% confidence interval (CI) = 1.10 to 1.34), decreased daily number of attacks (weighted mean difference (WMD) = -0.57, 95% CI = -1.14 to -0.01), and increased incidence of positive cold stimulation tests (RR = 1.64, 95% CI = 1.27 to 2.11). There was not enough evidence to associate acupuncture with decreased incidence of positive cold provocation tests. The network meta-analyses did not demonstrate significant results for the effectiveness of any acupuncture treatments (electroacupuncture or manual acupuncture ± moxibustion), compared with controls, in terms of remission incidence or daily number of attacks, possibly due to small sample sizes and a lack of statistical power.
The use of acupuncture may be effective for the treatment of Raynaud's syndrome in terms of increasing remission incidence, decreasing daily number of attacks and increasing incidences of positive cold stimulation tests. However, our findings should be interpreted with caution due to small sample sizes, very low quality of evidence and high risk of bias. Future large-scale RCTs are warranted.
通过对随机对照试验(RCT)的系统评价和荟萃分析,评估针刺治疗雷诺氏综合征的疗效。
从英语和中文数据库中检索从建库到 2020 年 9 月的研究。主要结局指标为缓解率、每日发作次数、冷刺激试验阳性率和冷激发试验阳性率。采用 meta 和 gemtc 进行荟萃分析和网络荟萃分析。
共纳入 6 项 RCT(n = 272 名参与者)进行荟萃分析。两两荟萃分析表明,针刺治疗可提高缓解率(风险比(RR)= 1.21,95%置信区间(CI)= 1.10 至 1.34),减少每日发作次数(加权均数差(WMD)= -0.57,95%CI = -1.14 至 -0.01),增加冷刺激试验阳性率(RR = 1.64,95%CI = 1.27 至 2.11)。针刺治疗降低冷激发试验阳性率的证据不足。网络荟萃分析未显示任何针刺治疗(电针或手针 ± 艾灸)与对照组相比在缓解率或每日发作次数方面具有显著疗效,可能是由于样本量小且缺乏统计学效能。
针刺治疗雷诺氏综合征可能有效,可提高缓解率,减少每日发作次数,增加冷刺激试验阳性率。但由于样本量小、证据质量极低和偏倚风险高,我们的结论应谨慎解释。需要进行大规模的 RCT 来进一步验证。